commercialization agreement
Mainz Biomed Partners with German Regional Lab on Colorectal Cancer Test Commercialization
The firm will co-brand its ColoAlert CRC detection assay with Laboratory Mönchengladbach and collaborate with the lab on marketing and education campaigns.
Prenetics Gets CE-IVD Mark for Handheld, Reusable SARS-CoV-2 Test System
The point-of-care system is designed to detect SARS-CoV-2 nucleic acid in nasal swab specimens placed in single-use test capsules.
Bio-Rad Laboratories, Seegene Partner for Infectious Disease MDx Development
The firms will develop and commercialize multiplex RT-PCR assays to detect infectious diseases for the US market.
GeninCode to Launch Cardiovascular Disease Risk Tests in US With Eversana
GeninCode offers a range of tests that combine genetic and clinical data to assess individuals for cardiovascular disease risk including Cardio inCode for heart attack.
Prevencio, Atlas Genomics to Commercialize Cardiac Blood Tests
The tests use Microsoft's Azure AI-based computing cloud platform for test algorithm processing and scoring and for report generation and delivery.